Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Aquestive Therapeutics, Inc.

NASDAQ: AQST · Life Sciences · 12 alerts · CIK 1398733

Share price
$3.76Close, Nov 16
Market cap
$473M
Shares outstanding
125.69MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Aquestive Therapeutics, Inc. filings on SEC EDGAR ↗

7:22 AM ET 8-K
Leadership Change

Aquestive Therapeutics Leadership Change

Aquestive Therapeutics appointed Richard J. Daly to its Board of Directors as a Class I director, effective October 14, 2026. Mr. Daly, a veteran life sciences executive with experience at AstraZeneca and Takeda, will receive an initial grant of 57,000 stock options as part of his non-employee director compensation package.

Counterparty
Richard J. Daly

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.